Dedicated to
the continued financial growth and health of the organization.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to
continue to grow our business and execute our
growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over
financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to
continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Western Australia's first cleanskin wine company is approaching its 10th anniversary and has
continued to achieve
growth even through numerous court battles with bigger rivals and the global
financial
«Our first quarter results were in line with our expectations and reflect the solid
growth of our proprietary commercial products and the
continued strength of our royalty and manufacturing business,» commented James Frates, Chief
Financial Officer of Alkermes.
«With the
financial support provided by Siva along with the strong base in the Dandaragan operations, the resulting quality of our extra virgin olive oil, the establishment of relationships with key bulk buyers, and the expansion of infrastructure and operating capacity, the Olea Australis Group intends to achieve its goal of an on going sustainable business that is a long - term participant in the
continued growth of extra virgin olive oil in Australia and throughout the world.»
Our strong
financial performance in Q1 2018
continues our record of successfully translating customer
growth into industry - leading revenue
growth and strong profitability.
The
financial crisis, the deepest bear market since the Great Depression, and the
continued growth of the emerging markets are just some of the contingencies directly affecting every portfolio in the world.
Gold company Evolution Mining has finalised its purchase of La Mancha Resources» Australian assets and secured $ 100 million in
financial firepower to
continue its
growth opportunities.
Mortgage broking wholesaler Australian Finance Group has upgraded its profit outlook for the 2016
financial year on the back of
continued growth.
David Wehner, Facebook's chief
financial officer, pointed to Asia - Pacific, especially India, as one of the most promising areas for
continued user
growth.
While
financial stocks with paltry payouts have the greatest yield
growth potential, Morrow thinks every U.S. bank will
continue upping its dividend.
«Our top pick among Japanese banks is Mitsubishi UFJ
Financial Group (MUFG), which is steadily enhancing its consolidated earnings power and is likely to
continue to achieve profit
growth.»
S&P Global Ratings Tuesday said the economic risks facing
financial institutions operating in New Zealand have heightened, partly due to
continued strong
growth in residential property prices.
The rapid
growth in these markets will likely
continue, as
financial institutions and health - care - related businesses embrace change through their technologies.
«Gross bookings have
continued to grow strongly across all channels and key geographic regions thus far in Q2, but
growth has decelerated compared to Q1,» chief
financial officer Daniel Finnegan said on an analyst call.
«Every week, we
continued to visit new bankers to talk about our
growth prospects, our sound
financial position, and our good credit history,» Wold recalls.
«As we
continue to progress toward long - term profitable
growth, it is necessary to reexamine the
financial performance of our store portfolio and adjust our national footprint accordingly,» CEO Myron Ullman said in a news release.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018
financial results; Gilead's ability to sustain
growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or
continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs);
continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The collective contributions of our alumni and employees have established a solid foundation for Moody's
continuing contribution to credit markets, business
growth and
financial success.
Extraordinary monetary policy measures were taken in the heat of the
financial crisis, and
continue to be applied five years later, as a necessary part of restoring economic
growth and stability.
Looking forward, these sorts of abrupt swings in
financial markets are likely to
continue, amid sluggish economic
growth, rising interest rates, high valuations and geopolitical uncertainties.
The report outlines barriers to the
growth and adoption of
financial technology (FinTech) in Canada and provides a number of recommendations to help regulators and policymakers
continue to promote FinTech innovation.
But as long as the PBoC can
continue to withstand pressure to lower interest rates — and it seems that the traditional poor relations between the PBoC and the CBRC have gotten worse in recent months, perhaps in part because the PBoC seems more determined to reduce
financial risk and more willing to accept lower
growth as the cost — China will move towards a system that uses capital much more efficiently and productively, and much of the tremendous waste that now occurs will gradually disappear.
Both United Technologies Corp. (NYSE: UTX) and Honeywell International Inc. (NYSE: HON) will
continue to benefit from global construction and aerospace sector
growth, according to Tigress
Financial Partners» Ivan Feinseth.
As long as we see accelerating
growth and stable
financial conditions, equity markets around the world will likely
continue to perform well.
Combining this with poor sales
growth results in a dismal outlook for earnings 3) the pressure on earnings will
continue to hurt capital spending, which is usually just a magnified image of earnings, 4) the same factors will
continue to raise default rates, causing earnings problems and debt downgrades among banks and
financial companies, 5) earnings shortfalls will also lead to
continued job cutbacks, with the unemployment rate rising to at least 5.5 % (indeed, once the unemployment rate has advanced by 0.5 % from its lows, it has never reversed until rising by least 1.5 % off those lows).
At the same time, the policy makers said the central bank should
continue to support favorable
financial conditions needed to sustain
growth, according to the minutes.
Combining your savings at one
financial provider is a good opportunity to make sure you have an appropriate asset mix — one that will balance your need for stability with
continued account
growth that will carry you through retirement.
Data provided represents a compilation of information from leading private company
financial research...
Continue reading GrowthCap's
Growth Equity Valuation Report: B2B Software →
We look forward to being part of Gibraltar's
continuing growth as an international
financial centre and its growing reputation as a Fintech hub.
But these monetary policy adjustments are likely to be gradual and cautious, as we
continue to face significant uncertainties and the headwinds to
growth from the
financial crisis have not fully abated.
The Bank of Canada will
continue to focus on what it does best: supporting the economic and
financial well - being of Canada by achieving low, stable and predictable inflation; by keeping core
financial market infrastructure safe; and by giving sound advice on
financial sector policies so that vulnerabilities do not get in the way of sustainable, productive
growth for all Canadians.
«For Facebook, we don't see a massive user
growth opportunity driving the company's
financial results,» says Rick Summer, an analyst at Morningstar, so the company will
continue pushing new features instead.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, operating in a highly competitive industry; changes in the retail landscape or the loss of key retail customers; the Company's ability to maintain, extend and expand its reputation and brand image; the impacts of the Company's international operations; the Company's ability to leverage its brand value; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue
growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's ability to realize the anticipated benefits from its cost savings initiatives; changes in relationships with significant customers and suppliers; the execution of the Company's international expansion strategy; tax law changes or interpretations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the United States and in various other nations in which we operate; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives we use; exchange rate fluctuations; risks associated with information technology and systems, including service interruptions, misappropriation of data or breaches of security; the Company's ability to protect intellectual property rights; impacts of natural events in the locations in which we or the Company's customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's ownership structure; the impact of future sales of its common stock in the public markets; the Company's ability to
continue to pay a regular dividend; changes in laws and regulations; restatements of the Company's consolidated
financial statements; and other factors.
«Cigna's strong first quarter performance was driven by the
continued, effective execution of our proven
growth strategy, which we expect to further accelerate through our pending combination with Express Scripts,» Cigna CEO David Cordani said Thursday in a release announcing the quarter's
financial results.
«Starbucks
continues to offer unit
growth in China and fill - in opportunities in the domestic market and has best in class
financials and returns,» Zolidis said.
Fiserv's 1Q Results Marked By Internal Revenue
Growth, 25 Percent Growth In Mobiliti Financial services technology firm posted results on Tuesday (May 1) that met on the top line, beat on the bottom and showed continued traction in internal revenue growth and digital ef
Growth, 25 Percent
Growth In Mobiliti Financial services technology firm posted results on Tuesday (May 1) that met on the top line, beat on the bottom and showed continued traction in internal revenue growth and digital ef
Growth In Mobiliti
Financial services technology firm posted results on Tuesday (May 1) that met on the top line, beat on the bottom and showed
continued traction in internal revenue
growth and digital ef
growth and digital efforts.
Coming into Tuesday's fourth - quarter
financial report, Johnson & Johnson shareholders were ready to see a tax reform hit but wanted
continued growth in revenue and earnings.
The developments maybe prominence the
continued drive to settle sidestep supports and other
financial entities amidst a duration of heightened activity in cryptocurrency markets and
growth around the tech more broadly.
While there were some concerns about
growth in credit and asset prices, there were a number of plausible explanations suggesting that the stability of the global
financial system would
continue.
The lower exchange rate, favourable domestic
financial conditions and the boost to household incomes from income tax cuts and increases in social benefit payments should
continue to support
growth in the period ahead.
«We
continue to expect domestic subscription revenue
growth to accelerate into the low teens starting in the first quarter,» Chief
Financial Officer Howard Averill said on a conference call with analysts.
Canada's demand - driven
growth worked well in the first few years after the
financial crisis, but
continued economic expansion requires re-balancing, says Gulati.
Nonetheless, the Committee
continues to anticipate that policy actions to stabilize
financial markets and institutions, fiscal and monetary stimulus, and market forces will contribute to a gradual resumption of sustainable economic
growth in a context of price stability.
But as electronic trading
continued its rapid
growth and acceptance in the
financial markets, NYMEX's plan to lure London IPE floor traders and trading away was a complete failure.
We believe our capital allocation strategy gives us
financial flexibility to pursue our
growth objectives and
continue to drive long - term shareholder value.»
«Our
financial system
continues to be resilient, and is being bolstered by stronger
growth and job creation, but we need to
continue to watch
financial vulnerabilities closely,» Governor Stephen Poloz said in a statement.
As a result, in many of our strategies, we are once again finding opportunities in stocks like Ally
Financial, Cummins, and Fiat Chrysler that are cheap on traditional «value» metrics while at the same time
continuing to hold «
growth» stocks that still do not trade at an appropriate premium.
«Connecting people to the networks that power the modern world — like
financial services — will unlock their economic potential and
continue a cycle of equitable economic
growth and poverty reduction,» said Shamina Singh, president of the Mastercard Center for Inclusive G
growth and poverty reduction,» said Shamina Singh, president of the Mastercard Center for Inclusive
GrowthGrowth.
While the lagged effects of the increases in interest rates in November and December are yet to flow through, the
continuing rapid pace of credit
growth is prima facie evidence that
financial conditions remain expansionary, especially when viewed in the context of lending rates that are still below the average of the past decade.